Tafenoquine

(Krintafel®)

Tafenoquine

Drug updated on 11/16/2023

Dosage FormTablet (oral; 150 mg)
Drug ClassAntimalarials
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for the radical cure (prevention of relapse) of Plasmodium vivax malaria in patients aged 16 years and older who are receiving appropriate antimalarial therapy for acute P. vivax infection.

Product Monograph / Prescribing Information

Document TitleYearSource
Krintafel (tafenoquine) Prescribing Information.2023GlaxoSmithKline, Research Triangle Park, NC

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines